Murray B. UROWITZ,David ISENBERG,Daniel WALLACE,Monique BEN-AM,Joshua LEVINE,Daphan PARAN
申请号：
US15673555
公开号：
US20180043016A1
申请日:
2017.08.10
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided is a method of treating a human subject suffering from systemic lupus erythematosus (SLE) and having at least one organ system categorized by the British Isles Lupus Assessment Group 2004 (“BILAG”) as category A (“BILAG A”) or at least two organ systems categorized as BILAG B. The method may include periodic administration to the human subject of one subcutaneous injection of 0.25 mg dose of Edratide every week, so as to treat the human subject.
